At a glance
- Originator Lacer
- Class Analgesics; Anti-inflammatories
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 01 Nov 2000 Discontinued - Preclinical for Pain in Spain (unspecified route)
- 31 Aug 1998 No-Development-Reported for Pain in Spain (Unknown route)
- 09 Jul 1996 New profile